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ABSTRACT
Objectives: Dental agenesis — a congenital lack of teeth — is one of the most frequently diagnosed developmental 
defects of dentition. Genetics is a crucial factor in the etiology of this disorder. Missing teeth can be caused by mutation 
in genes including MSX1, PAX9, AXIN2, and EDARADD. As is also true for ovarian cancer, over 20% of cases are associated 
with hereditary factors. Mutations in the BRCA1 and BRCA2 genes are said to be the most frequent of these. The aim of 
this study was to provide a systematic review of the literature on the coexistence of ovarian cancer and tooth agenesis. 
Material and methods: Publications were searched for in the online databases PubMed, SCOPUS, and Wiley Online Library. 
Current and archival issues of the Journal of Stomatology and Dental and Medical Problems were also searched. The key 
words used to find relevant publications were: ovarian cancer, hypodontia, and tooth agenesis, in various combinations. 
Results: Three publications were qualified to this review. Two of these compared the incidence of hypodontia in women 
with ovarian cancer and in healthy women, and the other was aimed at locating the gene responsible for the coexistence 
of ovarian cancer and tooth agenesis. As shown by these studies, women with ovarian cancer are (depending on the study) 
3.3 or 8.1 times more likely to have hypodontia than healthy women. However, no specific gene was found that might be 
responsible for the coexistence of ovarian cancer and tooth agenesis.
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INTRODUCTION
Tooth agenesis is one of the most common anomalies of 
dental development in humans [1]. The congenital absence 
of one to six teeth is called hypodontia, while the absence of 
more than six is called oligodontia [2]. The incidence of hy-
podontia in the Caucasian population ranges from 0.027% to 
10%, and is slightly more common in women [3]. Both forms 
of congenital absence of teeth may occur in isolated form or 
as a component of congenital malformations. Studies have 
shown that hypodontia of permanent teeth — excluding 
agenesis of the third molars — most often concerns the 
lower second premolar, then the upper lateral incisor and 
upper second premolar [3, 4]. These data coincide with the 
results of research conducted in the Orthodontic Jagiellon-
ian University Dental Clinic, Cracow, where the prevalence 
of congenital absence of teeth in patients treated ortho-
dontically in 1995–2003 and 2006–2007 was respectively 
9.5% and 8.9%; this was more common in women, and the 
most common missing tooth was the lower second pre-
molar [5, 6]. In the etiology of tooth agenesis, both genetic 
and environmental factors can be distinguished [7]. Three 
hundred genes take part in regulating the development of 
dentition [8]. The genes whose mutations have been de-
scribed as a cause of agenesis include MSX1, PAX9, AXIN2, 
and EDARADD [9–21].
Ovarian cancer  is the sixth most common malignant 
tumor in women in Poland and accounts for 5% of cases [22]. 
Morbidity increases with age, with 80% of cases diagnosed 
in people over 50 [22]. Five-year survival in the Polish pop-
ulation is around 50% [22]. Unfortunately, there are no 
characteristic symptoms of cancer, which contributes to 
its late detection [22]. It is estimated that 22% of the risk 
of ovarian cancer is associated with hereditary factors [23]. 
The strongest known genetic risk factors for epithelial ovar-
ian cancer  are the BRCA1 and BRCA2 genes [24].
Emerging publications show a possible coincidence of 
ovarian cancer and tooth agenesis, which has induced us 
to write a systematic review of the literature in this area. 
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The aim of the work is to present documented knowledge 
on this possible interdependence, obtained in a methodi-
cal manner from reliable sources of information. The dis-
semination of available information may help draw atten-
tion to this additional diagnostic aspect, which could be 
taken into account in oncological prevention and in the 
early detection of potential threats to women’s general 
health.
MATERIAL AND METHODS
To gather as many relevant publications as possible, we 
searched the following internet databases covering articles 
in the field of medicine and biological sciences: PubMed, 
SCOPUS, and Wiley Online Library. The key words used to 
find relevant research were: ovarian cancer, hypodontia, and 
tooth agenesis, in various combinations. The search was 
restricted to full-text articles published in English or Polish. 
There was no restriction on year of publication. Current and 
archival issues of the Journal of Stomatology and Dental and 
Medical Problems were also searched. 
All original publications regarding the relationship be-
tween ovarian cancer and tooth agenesis were approved 
for review. Literature reviews, editorial works, and letters to 
the editor have been excluded. If there was more than one 
article by the same author regarding the same study, only 
the first article was selected. 
RESULTS
The result of the database search was a total of 
850 items. After removal of 121 duplicates, 729 publications 
were available for the screening. According to the title and 
the abstract, 724 publications were removed because they 
were not related to the subject. Of the remaining 5 papers, 
3  were included after applying the inclusion and exclusion 
criteria (Fig. 1) [25–27]. No additional publications were 
found in the dental journals listed above. 
Records after database searched (n = 850)
Records after duplicates removed (n = 729)
Records excluded after title
and abstract screening (n = 724) 
Full-text articles assessed 
for eligibility (n = 5)
Full-text articles excluded (n = 2)
Reasons:
- Same data reported in 
another included study (1)
- Review papers (1)
Full-text articles included into
systematic review (n = 3)
Additional records identied
through manual search (n = 0)
Figure 1. Flow chart of literature search and study selection
709
Weronika Gawron-Jakubek et al., Coexistence of tooth agenesis and ovarian cancer — a systematic literature review
www. journals.viamedica.pl/ginekologia_polska
Two of the publications aimed at comparing the frequen-
cy of hypodontia in women with EOC (epithelial ovarian can-
cer ) and in healthy women, and the other attempted to locate 
the gene responsible for the coexistence of ovarian cancer and 
tooth agenesis [25–27]. All of the studies involved both wom-
en suffering from ovarian cancer and healthy women. The total 
number of examined patients was 485, including 220 patients 
suffering from EOC, of whom 43 had hypodontia [25–27]. Only 
two studies used control groups, which contained 220 people 
in total [25, 26]. Studies comparing the incidence of hypo-
dontia in sick and healthy women showed that women with 
ovarian cancer are (depending on the study) 3.3 or 8.1 times 
more likely to have hypodontia [25, 26]. It was also shown that, 
in patients with ovarian cancer, tooth agenesis occurs more of-
ten in the maxilla [25, 26]. These publications do not agree on 
the tooth that is missing most often — both the upper lateral 
incisor and the upper second premolar are mentioned [26, 25]. 
Only one study took into account the division of hypodontia 
into unilateral and bilateral. Agenesis was much more frequent 
on one side of the study group [25]. In both studies, more 
than 20% of patients with hypodontia and ovarian cancer 
had a family history of congenital absence of teeth [25, 26]. 
Genetic tests focused on mutations in the PAX9, EDA, WNT10A, 
MSX1, AXIN2, BARX1, BARX2, and BRCA1 genes [27]. One pa-
tient with coexisting ovarian cancer and tooth agenesis had 
mutations in the EDA and BRCA1 genes, another one only in 
the BRCA1 gene, and three in the WNT10A gene [27]. Unfortu-
nately, the research of Bonds et al. did not indicate any specific 
gene that might be responsible for the coexistence of EOC and 
tooth agenesis [27]. This information is presented in Table 1.
DISCUSSION
The above data indicate more frequent occurrence of 
tooth agenesis in women with ovarian cancer than in healthy 
women. Despite these data, from 2014 to September 2018, 
no new research publications confirmed the hypothesis of 
the coincidence of hypodontia and ovarian cancer. In 2016, 
a review paper by Iavazzo was published on the relationship 
between ovarian cancer and hypodontia; this qualified four 
publications for review [28], one of which was the publica-
tion of Fekonja et al. from 2015, which is a description of 
a study whose results were published a year earlier [27, 29], 
as can be seen from the location and year of the study, the 
size of the study and control group, and the frequency of 
hypodontia in both groups. This publication was therefore 
excluded from our review; it did, however, aim to compare 
data on the stage of advancement and the type of cancer 
in patients with and without hypodontia [29]. 
As mentioned earlier, genetic factors play a key role in 
the etiology of both ovarian cancer and tooth agenesis, 
and their co-occurrence may indicate overlapping genetic 
background. In a study conducted by Küchler et al., an in-
creased risk of a family history of cancer was observed in 
patients with confirmed tooth agenesis [30]. Chalothorn 
et al. reported a family history of ovarian cancer in thirty 
percent of women with hypodontia and EOC, compared to 
zero percent in women with hypodontia without EOC [26]. 
Although the gene responsible for the coincidence of tooth 
agenesis and ovarian cancer has not yet been identified, 
it is worth emphasizing that studies show that the genes 
responsible for congenitally missing teeth may also con-
tribute to the formation of cancer cells. Studies on a Finnish 
four-generation family showed that mutations within the 
AXIN2 gene simultaneously predispose to colon cancer and 
cause tooth agenesis [20]. This gene is also mentioned by 
Dimova et al. as a strong candidate for ovarian tumorigen-
esis [31]. Bonds et al. found mutations in the AXIN2 gene 
in one patient with ovarian cancer who did not have co-
existing hypodontia [25]. Mutations within the PAX9 gene 
result in isolated oligodontia in the molars [10–15]. Gerber 
Table 1. Publications on the relationship between ovarian cancer and tooth agenesis
Fekonja et al. [25] Chalothorn et al. [26] Bonds et al. [27]
Number of women in the study group 120 50 95
Number of women in the control group 120 100 _
Number of women with hypodontia and ovarian cancer 23 10* 10
Number of women with hypodontia and without ovarian cancer 8 3* –
Odds ratio 3.3 (95% CI, 0.12–7.01) 8.1 (95 % CI, 2.1–30.9) –
Most often missing tooth ** Upper second premolar Upper lateral incisor –
Distribution of hypodontia ** Unilaterally: 78.3%;Bilaterally: 21.7% – –
Family history of hypodontia ** 21.7 % 60% –
Family history of ovarian cancer ** – 30% –
Number of patients with a mutation in genes ** – – 5
* The criterion for inclusion in the group with hypodontia was tooth agenesis or microdontia 
** in women with ovarian cancer and hypodontia
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et al. showed a correlation between the progressive loss of 
PAX9 gene expression and an increase in the malignancy of 
dysplastic and cancerous epithelium of the esophagus [32]. 
PAX9 gene expression has also been detected in ovarian can-
cer cell lines [33]. In contrast, the MSX1 gene is considered 
a potential repressor in cell proliferation and cell cycle pro-
gression in human ovarian cancer cells [34]. Mutations in the 
same gene are mentioned among the reasons for the occur-
rence of tooth agenesis [17, 18]. So far, the relationship be-
tween the congenital absence of teeth and mutations in the 
BRCA1 and BRCA2 genes — considered to be the best-known 
risk factors for ovarian cancer—has not been demonstrated.
CONCLUSIONS
Though studies point to the existence of a correlation 
between ovarian cancer and tooth agenesis, there is pres-
ently no conclusive evidence for their common genetic 
basis. Proving this hypothesis would identify tooth agenesis 
as a risk factor for ovarian cancer, and thus contribute to 
increased detection of this cancer in the early stages of 
the disease.
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